FDA Permits Last-Resort Iclusig Use After Clinical Trial Deaths

By Jeff Overley (December 20, 2013, 7:04 PM EST) -- Two months after announcing a spate of deaths, the U.S. Food and Drug Administration on Friday allowed Ariad Pharmaceuticals Inc. to resume sales of leukemia drug Iclusig to a narrower universe of patients who will receive stronger warnings about the product's serious risks....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Related Sections

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!